ConductScience.org, home

Paper1783523

Antitumor activity and mechanism of action of the marine compound girodazole.

Lavelle F and 4 others. Invest New Drugs, 1991. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Antitumor activity and mechanism of action of the marine compound girodazole. Papers, record 1783523. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1783523

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antitumor activity and mechanism of action of the marine compound girodazole.
PubMed
Journal
Invest New Drugs
PubMed
Year
1991
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
0.66
iCite
Revised in PubMed
2019-10-22
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lavelle FF
2Zerial AA
3Fizames CC
4Rabault BB
5Curaudeau AA

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
ImidazolesMajor topic
Neoplasms, ExperimentalMajor topic
PropanolaminesMajor topic
Animals
Cell Division
DNA, Neoplasm
Humans
Leukemia P388
Mice
Mice, Inbred C3H
Mice, Inbred C57BL
Neoplasm Proteins
Neoplasm Transplantation
Protein Biosynthesis
RNA, Neoplasm
Rabbits
Transcription, Genetic
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16763877Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells.Biochim Biophys Acta1982https://conductscience.org/library/papers/6763877PubMed
25432063Cleavage of structural proteins during the assembly of the head of bacteriophage T4.Nature1970https://conductscience.org/library/papers/5432063PubMed
3823012An efficient mRNA-dependent translation system from reticulocyte lysates.Eur J Biochem1976https://conductscience.org/library/papers/823012PubMed
41256442Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis.Mol Pharmacol1976https://conductscience.org/library/papers/1256442PubMed
57011532Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin.Cancer Res1981https://conductscience.org/library/papers/7011532PubMed
61237080Harringtonine, an inhibitor of initiation of protein biosynthesis.Mol Pharmacol1975https://conductscience.org/library/papers/1237080PubMed
73001065Lycorine: a eukaryotic termination inhibitor?J Biol Chem1986https://conductscience.org/library/papers/3001065PubMed
84609488Negamycin inhibits termination of protein synthesis directed by phage f2 RNA in vitro.Biochim Biophys Acta1974https://conductscience.org/library/papers/4609488PubMed
95238986Stimulation of globin-chain initiation by hemin in the reticulocyte cell-free system.Proc Natl Acad Sci U S A1968https://conductscience.org/library/papers/5238986PubMed
103896117Eukaryotic protein synthesis.Annu Rev Biochem1985https://conductscience.org/library/papers/3896117PubMed
114682660Bruceantin, a new potent antileukemic simaroubolide from Brucea antidysenterica.J Org Chem1973https://conductscience.org/library/papers/4682660PubMed
126681537Antiviral and antitumor compounds from tunicates.Fed Proc1983https://conductscience.org/library/papers/6681537PubMed
13709555In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.Cancer Treat Rep1978https://conductscience.org/library/papers/709555PubMed
143298130Is the P388 murine tumor no longer adequate as a drug discovery model?Invest New Drugs1987https://conductscience.org/library/papers/3298130PubMed
152720652Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.Cancer Res1989https://conductscience.org/library/papers/2720652PubMed
166883351Clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: rationale for a three-stage strategy.Cancer Treat Rep1983https://conductscience.org/library/papers/6883351PubMed
176541580Do we need new chemosensitive experimental models?Eur J Cancer Clin Oncol1984https://conductscience.org/library/papers/6541580PubMed
186656641Preparation and use of nuclease-treated rabbit reticulocyte lysates for the translation of eukaryotic messenger RNA.Methods Enzymol1983https://conductscience.org/library/papers/6656641PubMed
192548717Antitumor activity and nucleic acid binding properties of dercitin, a new acridine alkaloid isolated from a marine Dercitus species sponge.Cancer Res1989https://conductscience.org/library/papers/2548717PubMed
20709550Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy.Cancer Treat Rep1978https://conductscience.org/library/papers/709550PubMed

See all 27 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42791378Halting translation by the letter with sequence-selective small molecules.Nat Chem Biol2026https://conductscience.org/library/papers/42791378PubMed
39794322Girolline is a sequence context-selective modulator of eIF5A activity.Nat Commun2025https://conductscience.org/library/papers/39794322PubMed
33280581A Quick Guide to Small-Molecule Inhibitors of Eukaryotic Protein Synthesis.Biochemistry (Mosc)2020https://conductscience.org/library/papers/33280581PubMed
32041255From Seabed to Bedside: A Review on Promising Marine Anticancer Compounds.Biomolecules2020https://conductscience.org/library/papers/32041255PubMed
25325155Evaluation of the toxicity of 5-aryl-2-aminoimidazole-based biofilm inhibitors against eukaryotic cell lines, bone cells and the nematode Caenorhabditis elegans.Molecules2014https://conductscience.org/library/papers/25325155PubMed
24117378Unbiased screening of marine sponge extracts for anti-inflammatory agents combined with chemical genomics identifies girolline as an inhibitor of protein synthesis.ACS Chem Biol2014https://conductscience.org/library/papers/24117378PubMed
21556392Biosynthesis, asymmetric synthesis, and pharmacology, including cellular targets, of the pyrrole-2-aminoimidazole marine alkaloids.Nat Prod Rep2011https://conductscience.org/library/papers/21556392PubMed
19209899A selective account of effective paradigms and significant outcomes in the discovery of inspirational marine natural products.J Nat Prod2009https://conductscience.org/library/papers/19209899PubMed
17321546The structures of antibiotics bound to the E site region of the 50 S ribosomal subunit of Haloarcula marismortui: 13-deoxytedanolide and girodazole.J Mol Biol2007https://conductscience.org/library/papers/17321546PubMed
7805184Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumors.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7805184PubMed
1437508New cytotoxic drugs and targets in oncology.Pharm Weekbl Sci1992https://conductscience.org/library/papers/1437508PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1783523

GET https://conductscience.org/api/papers/v1/1783523/references?page=2